Serenus Biotherapeutics looks to tap Africa's underdeveloped market
By Michael Fitzhugh
Tuesday, June 17, 2014
Sub-Saharan Africa's economic takeoff has carried a growing number of the region's 1.1 billion people ahead on a wave of innovation, bringing new advances in mobile commerce, bioagriculture and green energy. Innovative drugs from the West, however, have arrived much more slowly.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.